Abstract
19ISP is a nucleoside-modified mRNA-lipid nanoparticle vaccine that targets 19 Ixodes scapularis proteins. We demonstrate that adult I. scapularis have impaired fecundity when allowed to engorge on 19ISP-immunized rabbits. 19ISP, therefore, has the potential to interrupt the tick reproductive cycle, without triggering some of the other effects associated with acquired tick resistance. This may lead to the development of new strategies to reduce I. scapularis populations in endemic areas.
Subject terms: Immunology, Molecular biology
Introduction
Tick saliva is composed of a diverse set of bioactive molecules including proteins that facilitate tick feeding1,2. Some of these proteins have been associated with host immune responses that lead to acquired tick resistance (ATR)3. It was recently shown that a lipid nanoparticle containing the nucleoside-modified mRNAs encoding 19 tick salivary proteins, named 19ISP, can induce ATR. Guinea pigs immunized with 19ISP, and then exposed to Ixodes scapularis nymphs developed robust erythema at the tick bite sites, diminished tick engorgement, and early tick detachment4. Guinea pigs, however, are not a good laboratory model for adult I. scapularis feeding, molting and fecundity, which prevents a complete assessment of the influence of 19ISP on this stage of the tick life cycle.
ATR has also been observed in rabbits, dog, and cattle5–7, and rabbits are an excellent animal laboratory model for studying feeding by adult I. scapularis. We, therefore, tested the ability of 19ISP to induce ATR against adult Ixodes scapularis in rabbits with a focus on the ability of 19ISP to impact fecundity.
Rabbits were immunized with 19ISP, or a lipid nanoparticle containing firefly luciferase mRNA as a control and exposed to adult I. scapularis, in order to determine whether vaccination could interfere with the reproductive fitness of the ticks. The rabbits received 3 doses of 19ISP or the control formulation, given at 4-week intervals. Two weeks after the last boost, sera were obtained from the animals, and examined by ELISA for antibodies to antigens within 19ISP, at dilutions of 1:500, 1:5000 and 1:50,000. Rabbits elicited antibodies against 11 of the recombinant proteins tested (Salp12, Salp14, Salp15, Salp25A, Salp25C, Salp25D, Salp26A, IsPDIA3, P11, SG10, SG27) (Fig. 1). The rabbits did not show antibodies against TSLPI and TIX, which differs from the results observed when guinea pigs were immunized with the same batch of 19ISP vaccine4. The dose administered in rabbits was calculated in a similar way to that administered to guinea pigs4, based on the weight of the animals. When comparing antibody responses between rabbits and guinea pigs, the rabbits were generally shown to be less responsive to immunization with 19ISP4 . The rabbits also did not show a strong antibody response to Salp14 compared to guinea pigs immunized with 19ISP4, and this may have been one of the reasons for the absence of erythema in the rabbits. Salp14 was the antigen most commonly associated with erythema in guinea pigs exposed to I. scapularis nymphs, when all the 19 components within 19ISP were analyzed, either individually or in smaller combinations8,9.
One week after collecting the blood sample, the rabbits were exposed to adult I. scapularis. The ticks on the animals were monitored daily for attachment (Fig. 2A), and the weights of the collected ticks were determined (Fig. 2B). No significant differences were observed in the duration of time that I. scapularis remained attached to I9ISP-immunized or control rabbits. The engorgement weights of the ticks that fed on both groups of animals was also similar and no difference in erythema at the bite site was observed between the groups. These results are different from those observed in guinea pigs with nymphal I. scapularis4,8. In guinea pigs, early detachment or rejection of the nymphs was observed by 72 h. This influence of 19ISP mRNA immunization on the feeding time of nymphs, also resulted in a marked reduction of the weights of the recovered ticks. These data underscore the differences observed in rabbits using adult I. scapularis.
To assess fecundity, all ticks were evaluated for oviposition regardless of engorgement weight. Ticks were collected, stored individually, and allowed to complete their reproductive cycle. The weight of the egg mass generated by each female (Fig. 3A) was similar in ticks that fed on 19ISP-immunized or control rabbits. Females from both groups who did not posture or had a very low weight were also included as a part of Fig. 3A. Interestingly, a significant difference was observed in the percentage of eggs that hatched into larvae between I. scapularis that fed on 19ISP-immunized rabbits compared to the ticks that fed on control animals (Fig. 3B). These data suggest that the 19ISP vaccination can significantly impair a major parameter of I. scapularis reproduction, without influencing some of the other parameters associated with ATR.
Our study demonstrates that 19ISP immunization can significantly interfere with the ability of adult I. scapularis to successfully complete their reproductive cycle. In particular, the capacity of adults to produce viable larvae was substantially reduced. Interestingly, some differences in ATR were evident upon 19ISP immunization in guinea pigs and rabbits. An immune response to Salp14 in guinea pigs is linked to erythema at the tick bite site. Surprisingly, rabbits do not develop robust antibodies to Salp14 following 19ISP immunization, and these animals did not develop significant erythema at the tick bite site. These data underscore the importance of the different host immune response to specific tick proteins in the development of selected aspects of ATR. These data also help expand the principle that not all aspects of ATR, including erythema, tick engorgement and attachment and tick fecundity occur via the same mechanisms, or are associated with host responses to the same antigens.
Understanding the specific host responses associated with ATR is complex and requires the combination of different techniques. A detailed analysis of the bite site, including the examination of specific cellular responses using single cell RNA seq, as well as an examination of local innate, cellular and metabolic responses will help to guide future research. Adult I. scapularis commonly feed on deer to complete their life cycle, and it will be important to determine if the alterations in fecundity observed in the rabbit model extend to deer. Overall, these studies suggest that 19ISP can interfere with the fecundity of adult I. scapularis, and this finding opens new strategies to reduce tick populations in endemic areas.
Methods
Ethics
All experiments were conducted in accordance with the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health, USA. The animal protocols were approved by the Yale University Institutional Animal Care and Use Committee (YUIACUC—protocol number 2023-07941). The authors complied with the ARRIVE guidelines.
Ticks, animals and immunization
I. scapularis adults were obtained from the Oklahoma State University (Stillwater, OK) and maintained in an incubator at 23 °C and 90% relative humidity under a 14 h light, 10 h dark photoperiod. Female and male ticks were kept together for at least 48 h before challenge under the conditions mentioned above. New Zealand white rabbits (Charles River) were used for immunizations and tick challenge experiments.
Rabbits were immunized intradermally with 200 μg of 19ISP (n = 2) or luciferase mRNA as a control (n = 2). The animals were boosted twice at 4-week intervals. Three weeks after the last booster, rabbits were sedated with acepromazine (0.75 mg/kg) and 25 female and 25 male adult ticks were placed on the animal’s ears. Rabbits were monitored daily for evidence of tick rejection, recovery, and erythema at the bite site. The experiment was repeated three times, totaling 6 animals per group.
In addition, all the rabbits wore Elizabethan collars and the ear that received the tick was isolated with an adapted sock, which prevented the ticks from moving to another location. The animals were prevented from self-cleaning and received a daily dose of 1.25 mg/kg diazepam as a veterinary recommendation to reduce stress. During tick feeding, rabbits were housed individually in closed cages with wire grates suspended over water. The ticks that attached to the rabbits were allowed to detach naturally.
All recovered fed ticks were kept individually in plastic tubes sealed and maintained in an incubator under the conditions mentioned above until the end of egg laying (around 6 weeks). The egg mass was weighed and kept in the incubator until the hatching of the larvae (8 weeks). The hatching success was obtained by the value of visual count of larvae.
Laboratory methods
To assess antigen-specific antibody responses, ELISA was performed as described previously4. Briefly, 96-well ELISA plates were coated overnight with 250 ng of recombinant protein diluted in carbonate-bicarbonate buffer pH 9.6, washed with PBST (PBS with 0.05% Tween 20) and blocked with 3% bovine serum albumin for 1 h at 37° C. Rabbit sera were serially diluted (1:500, 1:5000, or 1:50,000) and incubated for 2 h at 37° C. Wells were washed, and reactivity was detected using goat anti-rabbit IgG-HRP and TMB HRP substrate solution (Thermo Fisher Scientific). TMB stop solution was added and the plates were read at 450 nm.
mRNA-lipid nanoparticles (LNPs) were formulated as previously described10 and this LNP contains 19 mRNAs encoding individual I. scapularis salivary proteins or firefly luciferase (Luc) mRNA4. mRNAs were transcribed from a linearized plasmid DNA template with a 101 nucleotide-long poly(A) tail and instead of UTP, N-1-methylpseudouridine (m1Ψ) 5’-triphosphate (TriLink) was used to generate modified nucleoside-containing mRNA. During the in vitro transcription, co-transcriptional capping was performed using the trinucleotide cap1 analog, CleanCap (TriLink). mRNAs were purified by cellulose purification, as described11, analyzed by gel electrophoresis and frozen at −20 °C. All mRNAs were combined and then encapsulated using an aqueous solution of mRNA at pH 4.0 and mixed with a solution of lipids dissolved in ethanol12,13. The solution contains an ionizable cationic lipid/ phosphatidylcholine/ cholesterol/ polyethylene glycol (PEG) lipid (proprietary of Acuitas, Vancouver, Canada) (50:10:38.5:1.5 mol/mol). RNA was mixed with the lipids at a ratio of ~ 0.05 (wt./wt.), LNP had a diameter of ~ 80 nm as measured by dynamic light scattering using a Zetasizer Nano ZS (Malvern Instruments Ltd, Malvern, UK) instrument, and stored at − 80 °C.
Statistical analyses
Data were analyzed using Prism 9.5.1 software (GraphPad Software, CA). Data are represented as the mean ± standard error of the mean (SEM) or mean with standard deviation (SD). The significance of the difference between control and experimental group was determined by Mann Whitney test. P ≤ 0.05 was considered statistically significant.
Acknowledgements
We thank Sukanya Narasimhan for her helpful suggestions in guiding this research work. This work was support by NIH grants AI165499 and AI138949, the Steven and Alexandra Cohen Foundation, and the Howard Hughes Medical Institute Emerging Pathogens Initiative.
Author contributions
E.F., and J.M. conceived the study. J.M., Y.C., G.E.L., K.D. performed and interpreted experiments (Rabbits immunization and tick challenge). J.M., Y.C., and E.M. performed and interpreted tick biological parameters. E.F., N.P., D.W., H.M., M.G.A., and G.D. designed and generated the mRNAs. Y.K.T. prepared the mRNA nanoparticles. J.M., and Y.C performed ELISAs. E. F., J.M. analyzed and interpreted data. J.M., and E.F. wrote the initial draft, performed statistical analysis, and generated figures. All authors read, edited, and approved the final manuscript.
Data availability
The data that support the findings of this study are available on request from the corresponding authors J.M and E.F.
Competing interests
N.P. and D.W. are named on a patent describing the use of nucleoside-modified mRNA in lipid nanoparticles as a vaccine platform. We have disclosed those interests fully to the University of Pennsylvania, and we have in place an approved plan for managing any potential conflicts arising from licensing of our patents. N.P. served on the mRNA strategic advisory board of Sanofi Pasteur in 2022. N.P. is a member of the scientific advisory board of AldexChem.
Footnotes
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Contributor Information
Jaqueline Matias, Email: jaqmatias@hotmail.com.
Erol Fikrig, Email: erol.fikrig@yale.edu.
References
- 1.Dai J, et al. Tick histamine release factor is critical for Ixodes scapularis engorgement and transmission of the lyme disease agent. PLoS Pathog. 2010;6:e1001205. doi: 10.1371/journal.ppat.1001205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Schuijt TJ, et al. Factor Xa activation of factor V is of paramount importance in initiating the coagulation system: Lessons from a tick salivary protein. Circulation. 2013;128:254–266. doi: 10.1161/CIRCULATIONAHA.113.003191. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Narasimhan S, et al. Ixodes scapularis saliva components that elicit responses associated with acquired tick-resistance. Ticks Tick Borne Dis. 2020;11:101369. doi: 10.1016/j.ttbdis.2019.101369. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Sajid, A. et al. mRNA vaccination induces tick resistance and prevents transmission of the Lyme disease agent. Sci. Transl. Med.13, eabj9827. 10.1126/scitranslmed.abj9827 (2021). [DOI] [PubMed]
- 5.Fivaz BH, Tucker S, Petney T. Cross-resistance between instars of the brown ear-tick Rhipicephalus appendiculatus (Acarina: Ixodidae) Exp. Appl. Acarol. 1991;11:323–326. doi: 10.1007/BF01202879. [DOI] [PubMed] [Google Scholar]
- 6.Gebbia JA, Bosler EM, Evans RD, Schneider EM. Acquired resistance in dogs to repeated infestation with Ixodes scapularis (Acari: Ixodidae) reduces tick viability and reproductive success. Exp. Appl. Acarol. 1995;19:593–605. doi: 10.1007/BF00048814. [DOI] [PubMed] [Google Scholar]
- 7.Hewetson RW. The inheritance of resistance by cattle to cattle tick. Aust. Vet. J. 1972;48:299–303. doi: 10.1111/j.1751-0813.1972.tb05161.x. [DOI] [PubMed] [Google Scholar]
- 8.Matias J, et al. Specific mRNA lipid nanoparticles and acquired resistance to ticks. Vaccine. 2023 doi: 10.1016/j.vaccine.2023.06.081. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Matias J, et al. Tick immunity using mRNA, DNA and protein-based Salp14 delivery strategies. Vaccine. 2021;39:7661–7668. doi: 10.1016/j.vaccine.2021.11.003. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Freyn AW, et al. A multi-targeting, nucleoside-modified mRNA influenza virus vaccine provides broad protection in mice. Mol. Ther. 2020;28:1569–1584. doi: 10.1016/j.ymthe.2020.04.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Baiersdorfer M, et al. A facile method for the removal of dsRNA contaminant from in vitro-transcribed mRNA. Mol. Ther. Nucleic Acids. 2019;15:26–35. doi: 10.1016/j.omtn.2019.02.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Maier MA, et al. Biodegradable lipids enabling rapidly eliminated lipid nanoparticles for systemic delivery of RNAi therapeutics. Mol. Ther. 2013;21:1570–1578. doi: 10.1038/mt.2013.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Jayaraman M, et al. Maximizing the potency of siRNA lipid nanoparticles for hepatic gene silencing in vivo. Angew Chem. Int. Ed. Engl. 2012;51:8529–8533. doi: 10.1002/anie.201203263. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
The data that support the findings of this study are available on request from the corresponding authors J.M and E.F.